Duloxetine vs. Placebo in the Treatment of Osteoarthritis Knee Pain

Osteoarthritis Knee Pain Clinical Trial

Official title:
Protocol F1J-MC-HMFG Duloxetine 60 to 120 mg Versus Placebo in the Treatment of Patients With Osteoarthritis Knee Pain

Status Completed

Clinical Trial Summary

The primary purpose of this study is to determine if duloxetine reduces pain severity in patients with osteoarthritis knee pain.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00433290
Study type	Interventional
Source	Eli Lilly and Company
Contact
Status	Completed
Phase	Phase 3
Start date	February 2007
Completion date	May 2008

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01018680` - A Study Comparing Duloxetine Versus Placebo in Patients Taking a Nonsteroidal Anti-inflammatory Drug (NSAID) for Knee Pain Due to Osteoarthritis	Phase 3
Completed	`NCT00790790` - A Study in the Treatment of Osteoarthritis Knee Pain	Phase 2
Completed	`NCT00408421` - Duloxetine Versus Placebo for Osteoarthritis Knee Pain	Phase 3
Completed	`NCT00945945` - A Study of Duloxetine in Patients With Osteoarthritis Knee Pain	Phase 3
Completed	`NCT03434197` - Safety and Efficacy of SFPP in Knee Osteoarthritis	Phase 3